A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dabrafenib Impurity 44 | CAS 630-22-8 - Request Quote

Picture of Dabrafenib Impurity 44

Dabrafenib Impurity 44

SZ CAT No:SZ-D120060
CAS No
630-22-8
Mol.F.
C5H11NS
Mol.Wt.
117.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dabrafenib Impurity 44 is chemically 2,2-Dimethylpropanethioamide. Dabrafenib Impurity 44 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 44 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 630-22-8

Purchase 630-22-8

Order 630-22-8

Enquire 630-22-8

price of 630-22-8

630-22-8 Supplier

630-22-8 Manufacturer

630-22-8 Exporter

buy high quality Dabrafenib Impurity 44

Purchase Dabrafenib Impurity 44

Dabrafenib Impurity 44 suppliers

Dabrafenib Impurity 44 manufacturers

Dabrafenib Impurity 44 price

Order Dabrafenib Impurity 44

Enquire Dabrafenib Impurity 44

Dabrafenib Impurity 44 cost

Dabrafenib Impurity 44 Supplier

Dabrafenib Impurity 44 Distributor

Dabrafenib Impurity 44 for Method Validation

Dabrafenib Reference Standard

Dabrafenib Impurity 44 for ANDA Filing

Dabrafenib Impurity 44 for Forced Degradation Studies

Dabrafenib Impurity 44 Identification Standards

Dabrafenib Impurity 44 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,